Acoustic neuroma risk factors
|
Acoustic neuroma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Acoustic neuroma risk factors On the Web | |
|
American Roentgen Ray Society Images of Acoustic neuroma risk factors | |
|
Risk calculators and risk factors for Acoustic neuroma risk factors | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Mohsen Basiri M.D.
Overview
Common risk factors in the development of acoustic neuroma are neurofibromatosis type 2 and radiation exposure. Less common risk factors include sporadic defects in tumor suppressor genes, exposure to loud noise, history of parathyroid adenoma, and the use of cellular phones.
Risk Factors
Common Risk Factors
- Neurofibromatosis type 2[1][2]
- Childhood exposure to radiation of the head and neck[3][4]
- Exposure to high-dose ionizing radiation[5][6]
Less Common Risk Factors
- Sporadic defects in tumor suppressor genes in some individuals
- Exposure to loud noise on a consistent basis[7]
- A concomitant history of having had a parathyroid adenoma[8]
- The use of cellular phones[9][10][11][12][13]
References
- ↑ Michael E. Sughrue, Andrea H. Yeung, Martin J. Rutkowski, Steven W. Cheung & Andrew T. Parsa (2011). "Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics". Journal of neurosurgery. 114 (2): 359–366. doi:10.3171/2009.10.JNS091135. PMID 19943731. Unknown parameter
|month=ignored (help) - ↑ M. Ruggieri, A. D. Pratico, A. Serra, L. Maiolino, S. Cocuzza, P. Di Mauro, L. Licciardello, P. Milone, G. Privitera, G. Belfiore, M. Di Pietro, F. Di Raimondo, A. Romano, A. Chiarenza, M. Muglia, A. Polizzi & D. G. Evans (2016). "Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies". Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 36 (5): 345–367. doi:10.14639/0392-100X-1093. PMID 27958595. Unknown parameter
|month=ignored (help) - ↑ Arthur B. Schneider, Elaine Ron, Jay Lubin, Marilyn Stovall, Eileen Shore-Freedman, Jocelyn Tolentino & Barbara J. Collins (2008). "Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck". Neuro-oncology. 10 (1): 73–78. doi:10.1215/15228517-2007-047. PMID 18079359. Unknown parameter
|month=ignored (help) - ↑ E. Shore-Freedman, C. Abrahams, W. Recant & A. B. Schneider (1983). "Neurilemomas and salivary gland tumors of the head and neck following childhood irradiation". Cancer. 51 (12): 2159–2163. PMID 6850504. Unknown parameter
|month=ignored (help) - ↑ Oyebode Taiwo, Deron Galusha, Baylah Tessier-Sherman, Sharon Kirsche, Linda Cantley, Martin D. Slade, Mark R. Cullen & A. Michael Donoghue (2014). "Acoustic neuroma: potential risk factors and audiometric surveillance in the aluminium industry". Occupational and environmental medicine. 71 (9): 624–628. doi:10.1136/oemed-2014-102094. PMID 25015928. Unknown parameter
|month=ignored (help) - ↑ Mantao Chen, Zuoxu Fan, Xiujue Zheng, Fei Cao & Liang Wang (2016). "Risk Factors of Acoustic Neuroma: Systematic Review and Meta-Analysis". Yonsei medical journal. 57 (3): 776–783. doi:10.3349/ymj.2016.57.3.776. PMID 26996581. Unknown parameter
|month=ignored (help) - ↑ Colin G. Edwards, Judith A. Schwartzbaum, Stefan Lonn, Anders Ahlbom & Maria Feychting (2006). "Exposure to loud noise and risk of acoustic neuroma". American journal of epidemiology. 163 (4): 327–333. doi:10.1093/aje/kwj044. PMID 16357108. Unknown parameter
|month=ignored (help) - ↑ L. Magnus Backlund, Dan Grander, Lena Brandt, Per Hall & Anders Ekbom (2005). "Parathyroid adenoma and primary CNS tumors". International journal of cancer. 113 (6): 866–869. doi:10.1002/ijc.20743. PMID 15515018. Unknown parameter
|month=ignored (help) - ↑ Seung-Kwon Myung, Woong Ju, Diana D. McDonnell, Yeon Ji Lee, Gene Kazinets, Chih-Tao Cheng & Joel M. Moskowitz (2009). "Mobile phone use and risk of tumors: a meta-analysis". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27 (33): 5565–5572. doi:10.1200/JCO.2008.21.6366. PMID 19826127. Unknown parameter
|month=ignored (help) - ↑ M. P. Little, P. Rajaraman, R. E. Curtis, S. S. Devesa, P. D. Inskip, D. P. Check & M. S. Linet (2012). "Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States". BMJ (Clinical research ed.). 344: e1147. doi:10.1136/bmj.e1147. PMID 22403263. Unknown parameter
|month=ignored (help) - ↑ Isabelle Deltour, Anssi Auvinen, Maria Feychting, Christoffer Johansen, Lars Klaeboe, Risto Sankila & Joachim Schuz (2012). "Mobile phone use and incidence of glioma in the Nordic countries 1979-2008: consistency check". Epidemiology (Cambridge, Mass.). 23 (2): 301–307. doi:10.1097/EDE.0b013e3182448295. PMID 22249239. Unknown parameter
|month=ignored (help) - ↑ Baan, Robert; Grosse, Yann; Lauby-Secretan, Béatrice; El Ghissassi, Fatiha; Bouvard, Véronique; Benbrahim-Tallaa, Lamia; Guha, Neela; Islami, Farhad; Galichet, Laurent; Straif, Kurt (2011). "Carcinogenicity of radiofrequency electromagnetic fields". The Lancet Oncology. 12 (7): 624–626. doi:10.1016/S1470-2045(11)70147-4. ISSN 1470-2045.
- ↑ "Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case–control study". Cancer Epidemiology. 35 (5): 453–464. 2011. doi:10.1016/j.canep.2011.05.012. ISSN 1877-7821.